NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151026&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq.

image for news Recover Investment Losses: Levi & Korsinsky Files Class Action Against DoubleVerify Holdings, Inc. (DV)

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / WHY: New York, N.Y., May 30, 2025.

image for news ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Open Lending Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LPRO

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in DoubleVerify Holdings, Inc. ("DoubleVerify Holdings, Inc." or the "Company") (NYSE: DV) of a class action securities lawsuit.

image for news Levi & Korsinsky Reminds DoubleVerify Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 21, 2025 – DV

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit.

image for news Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – VTRS

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Civitas Resources, Inc. ("Civitas Resources" or the "Company") (NYSE: CIVI) of a class action securities lawsuit.

image for news Shareholders that lost money on Civitas Resources, Inc. (CIVI) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Everus Construction Group, Inc. ("Everus Construction " or the "Company") (NYSE: ECG) of a class action securities lawsuit.

image for news Everus Construction Group, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – ECG

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.

image for news Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join – Contact Levi & Korsinsky

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in UnitedHealth Group Incorporated ("UnitedHealth Group Incorporated" or the "Company") (NYSE: UNH) of a class action securities lawsuit.

image for news Class Action Filed Against UnitedHealth Group Incorporated (UNH) - July 7, 2025 Deadline to Join – Contact Levi & Korsinsky

MicroStrategy Rises 28% Year to Date: Buy, Sell or Hold the Stock? — Neutral

MSTR   Zacks Investment Research — May 30, 2025

MSTR is up 27.9% year to date, fueled by bitcoin gains and rising subscriptions, but a premium valuation makes the stock risky.

image for news MicroStrategy Rises 28% Year to Date: Buy, Sell or Hold the Stock?

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151019&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by July 22, 2025 to Join Class Action Against Organon & Co. (OGN)

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / WHY: New York, N.Y., May 30, 2025.

image for news ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm - CODI

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.

image for news Ongoing Securities Investigation into UroGen Pharma Ltd. (URGN) - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151021&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

image for news CODI ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Compass Group Diversified Holdings, LLC - July 8, 2025 Deadline

Veeva to Present at Upcoming Investor Conferences — Neutral

VEEV   PRNewsWire — May 30, 2025

PLEASANTON, Calif. , May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY.

image for news Veeva to Present at Upcoming Investor Conferences

Canopy Growth shares slide after wider loss, lower revenue in Q4 — Negative

CGC   Proactive Investors — May 30, 2025

Shares of Canopy Growth Corporation (TSX:WEED, NYSE:CGC) tumbled on Friday after the Canadian cannabis producer reported a wider quarterly loss and a decline in revenue, as it continues to grapple with ongoing operational and market challenges. The stock fell over 21% in New York and more than 19% in Toronto following the company's fiscal fourth-quarter results.

image for news Canopy Growth shares slide after wider loss, lower revenue in Q4

Marvell: When The Market Thinks Good Earnings Still Aren't Good Enough — Negative

MRVL   Seeking Alpha — May 30, 2025

Marvell Technology delivered strong FQ1 results, driven by 76% YoY data center revenue growth, but near-term growth may have peaked. Revenue concentration in Amazon and the delayed Microsoft ramp create execution risks, especially as AI CapEx plans face uncertainty. Valuation has normalized, offering an attractive risk/reward for long-term investors despite the potential for sideways price action.

image for news Marvell: When The Market Thinks Good Earnings Still Aren't Good Enough

Locate Large Value With This SMIDcap ETF — Positive

NBSM   ETF Trends — May 30, 2025

With the April sell-off in the rearview mirror, investors may want to start looking at SMIDcap opportunities again to capture value-tilted upside. That's because their large-cap counterparts have recovered.

image for news Locate Large Value With This SMIDcap ETF

Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold? — Positive

GILD   Zacks Investment Research — May 30, 2025

GILD stock jumps 21.1% YTD as HIV dominance, lenacapavir progress, and liver drug approval offset oncology pressures. However, we recommend investors remain on the sidelines at current levels.

image for news Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold?

Bath & Body Works Q1 Earnings Beat Estimates, Sales Rise Y/Y — Positive

BBWI   Zacks Investment Research — May 30, 2025

BBWI reports higher earnings and sales in the fiscal first quarter, boosted by product innovation and strong supply-chain performance.

image for news Bath & Body Works Q1 Earnings Beat Estimates, Sales Rise Y/Y

Transaction in Own Shares — Neutral

SHEL   GlobeNewsWire — May 30, 2025

Transaction in Own Shares 30 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 30 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 30/05/2025 536,589 £24.7250 £24.4300 £24.5634 LSE GBP 30/05/2025 190,255 £24.7200 £24.4300 £24.5692 Chi-X (CXE) GBP 30/05/2025 111,156 £24.7200 £24.4550 £24.5842 BATS (BXE) GBP 30/05/2025 446,721 €29.5650 €29.2100 …

image for news Transaction in Own Shares